SCHEMBL30837943

SCHEMBL30837943

COc1ccc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)cc1OC(C)C

nearest known ligand 0.93

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.93
PDE7B Q9NP56 5/20 0.93
PDE8A O60658 3/20 0.93
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 2/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.38
THRB P10828 1/20 0.38
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
OPRM1 P35372 5/20 0.36
OPRL1 P41146 5/20 0.36
OPRD1 P41143 1/20 0.36
P2RX3 P56373 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100878 1.00 PDE7A (0.93) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100852 0.97 PDE7A (0.93) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837796 0.97 PDE7A (0.93) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100704 0.96 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837881 0.96 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100239 0.92 PDE7A (0.93) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837841 0.92 PDE7A (0.93) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837897 0.92 PDE7A (0.86) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100039 0.92 PDE7A (0.86) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL99932 0.92 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed